Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TERAZOSIN Cause Hypovolaemia? 8 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hypovolaemia have been filed in association with TERAZOSIN (terazosin). This represents 1.5% of all adverse event reports for TERAZOSIN.

8
Reports of Hypovolaemia with TERAZOSIN
1.5%
of all TERAZOSIN reports
0
Deaths
7
Hospitalizations

How Dangerous Is Hypovolaemia From TERAZOSIN?

Of the 8 reports, 7 (87.5%) required hospitalization.

Is Hypovolaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TERAZOSIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does TERAZOSIN Cause?

Therapeutic product effect incomplete (75) Asthma (66) Dyspnoea (60) Drug ineffective (56) Dizziness (47) Cough (46) Chest pain (42) Malaise (40) Hospitalisation (37) Drug hypersensitivity (36)

What Other Drugs Cause Hypovolaemia?

FUROSEMIDE (346) METFORMIN (281) EMPAGLIFLOZIN (150) SPIRONOLACTONE (123) DEXAMETHASONE (117) HYDROCHLOROTHIAZIDE (94) PREDNISONE (91) LISINOPRIL (86) METOPROLOL (84) ACETAMINOPHEN (77)

Which TERAZOSIN Alternatives Have Lower Hypovolaemia Risk?

TERAZOSIN vs TERAZOSIN\TERAZOSIN TERAZOSIN vs TERBINAFINE TERAZOSIN vs TERBINAFINE\TERBINAFINE TERAZOSIN vs TERBUTALINE TERAZOSIN vs TERCONAZOLE

Related Pages

TERAZOSIN Full Profile All Hypovolaemia Reports All Drugs Causing Hypovolaemia TERAZOSIN Demographics